1458 related articles for article (PubMed ID: 19636003)
21. Value of D-dimer testing for the exclusion of pulmonary embolism in patients with previous venous thromboembolism.
Le Gal G; Righini M; Roy PM; Sanchez O; Aujesky D; Perrier A; Bounameaux H
Arch Intern Med; 2006 Jan; 166(2):176-80. PubMed ID: 16432085
[TBL] [Abstract][Full Text] [Related]
22. High plasma D-dimer level is associated with decreased survival in patients with lung cancer.
Altiay G; Ciftci A; Demir M; Kocak Z; Sut N; Tabakoglu E; Hatipoglu ON; Caglar T
Clin Oncol (R Coll Radiol); 2007 Sep; 19(7):494-8. PubMed ID: 17513096
[TBL] [Abstract][Full Text] [Related]
23. Longitudinal analysis of hemostasis biomarkers in cancer patients during antitumor treatment.
Reitter EM; Kaider A; Ay C; Quehenberger P; Marosi C; Zielinski C; Pabinger I
J Thromb Haemost; 2016 Feb; 14(2):294-305. PubMed ID: 26662117
[TBL] [Abstract][Full Text] [Related]
24. Circulating procoagulant microparticles in cancer patients.
Thaler J; Ay C; Weinstabl H; Dunkler D; Simanek R; Vormittag R; Freyssinet JM; Zielinski C; Pabinger I
Ann Hematol; 2011 Apr; 90(4):447-53. PubMed ID: 20981426
[TBL] [Abstract][Full Text] [Related]
25. Prognostic value of plasma D-dimer levels in patients with colorectal cancer.
Kilic M; Yoldas O; Keskek M; Ertan T; Tez M; Gocmen E; Koc M
Colorectal Dis; 2008 Mar; 10(3):238-41. PubMed ID: 17868411
[TBL] [Abstract][Full Text] [Related]
26. Preoperative plasma D-dimer levels predict survival in patients with operable non-small cell lung cancer independently of venous thromboembolism.
Zhang PP; Sun JW; Wang XY; Liu XM; Li K
Eur J Surg Oncol; 2013 Sep; 39(9):951-6. PubMed ID: 23810331
[TBL] [Abstract][Full Text] [Related]
27. Venous thromboembolism in patients with colorectal cancer: incidence and effect on survival.
Alcalay A; Wun T; Khatri V; Chew HK; Harvey D; Zhou H; White RH
J Clin Oncol; 2006 Mar; 24(7):1112-8. PubMed ID: 16505431
[TBL] [Abstract][Full Text] [Related]
28. [Predictive value of coagulative molecular markers for thromboembolism in patients with nonvalvular atrial fibrillation: prospective five-year follow-up study].
Enta K; Iwade K; Aosaki M; Uchida T; Kasanuki H
J Cardiol; 2004 Dec; 44(6):223-32. PubMed ID: 15638220
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of Wells score and repeated D-dimer in diagnosing venous thromboembolism.
Ljungqvist M; Söderberg M; Moritz P; Ahlgren A; Lärfars G
Eur J Intern Med; 2008 Jun; 19(4):285-8. PubMed ID: 18471679
[TBL] [Abstract][Full Text] [Related]
30. Risk factors for chemotherapy-associated venous thromboembolism in a prospective observational study.
Khorana AA; Francis CW; Culakova E; Lyman GH
Cancer; 2005 Dec; 104(12):2822-9. PubMed ID: 16284987
[TBL] [Abstract][Full Text] [Related]
31. Venous thromboembolism in carriers of the Factor V Leiden mutation and in patients without known thrombophilic risk factor; prediction of recurrence and APC-PCI complex concentration and/or soluble thrombomodulin antigen and activity.
Strandberg K; Svensson PJ; Ohlin AK
Thromb Res; 2007; 121(2):145-51. PubMed ID: 17499343
[TBL] [Abstract][Full Text] [Related]
32. Incidence of venous thromboembolism in patients with ovarian cancer undergoing platinum/paclitaxel-containing first-line chemotherapy: an exploratory analysis by the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group.
Fotopoulou C; duBois A; Karavas AN; Trappe R; Aminossadati B; Schmalfeldt B; Pfisterer J; Sehouli J;
J Clin Oncol; 2008 Jun; 26(16):2683-9. PubMed ID: 18509180
[TBL] [Abstract][Full Text] [Related]
33. Tests predictive of thrombosis in cancer.
Ay C; Pabinger I
Thromb Res; 2010 Apr; 125 Suppl 2():S12-5. PubMed ID: 20433990
[TBL] [Abstract][Full Text] [Related]
34. Plasma coagulation markers in patients with solid tumors and venous thromboembolic disease receiving oral anticoagulation therapy.
Sallah S; Husain A; Sigounas V; Wan J; Turturro F; Sigounas G; Nguyen NP
Clin Cancer Res; 2004 Nov; 10(21):7238-43. PubMed ID: 15534097
[TBL] [Abstract][Full Text] [Related]
35. Thrombin generation and D-dimer concentrations in a patient cohort investigated for venous thromboembolism. Relations to venous thrombosis, factor V Leiden and prothrombin G20210A. The LIST study.
Chaireti R; Jennersjö C; Lindahl TL
Thromb Res; 2009 Jun; 124(2):178-84. PubMed ID: 19232683
[TBL] [Abstract][Full Text] [Related]
36. Circulating P-selectin and the risk of recurrent venous thromboembolism.
Kyrle PA; Hron G; Eichinger S; Wagner O
Thromb Haemost; 2007 Jun; 97(6):880-3. PubMed ID: 17549288
[TBL] [Abstract][Full Text] [Related]
37. Markers of plasma coagulation and fibrinolysis after acute deep venous thrombosis.
Meissner MH; Zierler BK; Bergelin RO; Chandler WC; Manzo RA; Strandness DE
J Vasc Surg; 2000 Nov; 32(5):870-80. PubMed ID: 11054218
[TBL] [Abstract][Full Text] [Related]
38. Cardiovascular risk factors in idiopathic compared to risk-associated venous thromboembolism: A focus on fibrinogen, factor VIII, and high-sensitivity C-reactive protein (hs-CRP).
Luxembourg B; Schmitt J; Humpich M; Glowatzki M; Dressler D; Seifried E; Lindhoff-Last E
Thromb Haemost; 2009 Oct; 102(4):668-75. PubMed ID: 19806251
[TBL] [Abstract][Full Text] [Related]
39. Venous thromboembolism in trauma: a local manifestation of systemic hypercoagulability?
Meissner MH; Chandler WL; Elliott JS
J Trauma; 2003 Feb; 54(2):224-31. PubMed ID: 12579044
[TBL] [Abstract][Full Text] [Related]
40. Elevated levels of D-dimer and fragment 1+2 upon central venous catheter insertion and factor V Leiden predict subclavian vein thrombosis.
Lee A
Haematologica; 2005 Apr; 90(4):437. PubMed ID: 15820933
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]